Editors pick

Poorly soluble APIs now represent the majority of the pharmaceutical development pipeline. Dissolution and oral bioavailability are determined by molecular solubility, surface wetting behavior, solid-state stability, and how the formulation interacts with the GI environment from first contact onward. Amorphous dispersions, lipid systems, nanocrystals, and co-crystals each rely on different surface mechanisms to deliver their intended advantage.

Powder segregation diagnosis starts by locating where the blend loses uniformity. Some [...]

Bulk powder behavior is not controlled by particle size alone. In many [...]

A powder can look easy to handle in a funnel test and [...]

Article updated February 2026 Porosity controls hydration speed, dissolution, compressibility, and [...]

Concentrated refractory alloy powders for rocket propulsion only create value when you [...]

Silicon anode powder fails in production for predictable reasons. Particle morphology, oxide [...]

In the Holiday rush, winter humidity shifts and faster throughput can break [...]

Triboelectric charging forms when powders contact and separate, creating a shifting charge [...]

Smart powder processing in additive manufacturing links engineered powders, real-time sensor data, [...]

The powder plateau S-curve explains why progress is incremental and why expectations [...]

The relevance of powder testing for circular economy powder usage. Circular production [...]